{"cik":1863294,"taxonomy":"us-gaap","tag":"LiabilitiesCurrent","label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","entityName":"DA32 LIFE SCIENCE TECH ACQUISITION CORP.","units":{"USD":[{"end":"2021-09-30","val":216825,"accn":"0001193125-21-329827","fy":2021,"fp":"Q3","form":"10-Q","filed":"2021-11-15","frame":"CY2021Q3I"},{"end":"2021-12-31","val":286516,"accn":"0001193125-22-091916","fy":2021,"fp":"FY","form":"10-K","filed":"2022-03-31"},{"end":"2021-12-31","val":286516,"accn":"0001193125-22-150065","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-13"},{"end":"2021-12-31","val":286516,"accn":"0001193125-22-221227","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-15"},{"end":"2021-12-31","val":286516,"accn":"0001193125-22-282602","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-10"},{"end":"2021-12-31","val":286516,"accn":"0001193125-23-083849","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-29","frame":"CY2021Q4I"},{"end":"2022-03-31","val":307045,"accn":"0001193125-22-150065","fy":2022,"fp":"Q1","form":"10-Q","filed":"2022-05-13","frame":"CY2022Q1I"},{"end":"2022-06-30","val":303274,"accn":"0001193125-22-221227","fy":2022,"fp":"Q2","form":"10-Q","filed":"2022-08-15","frame":"CY2022Q2I"},{"end":"2022-09-30","val":584005,"accn":"0001193125-22-282602","fy":2022,"fp":"Q3","form":"10-Q","filed":"2022-11-10","frame":"CY2022Q3I"},{"end":"2022-12-31","val":1050033,"accn":"0001193125-23-083849","fy":2022,"fp":"FY","form":"10-K","filed":"2023-03-29"},{"end":"2022-12-31","val":1050033,"accn":"0001193125-23-143535","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-12","frame":"CY2022Q4I"},{"end":"2023-03-31","val":1352980,"accn":"0001193125-23-143535","fy":2023,"fp":"Q1","form":"10-Q","filed":"2023-05-12","frame":"CY2023Q1I"}]}}